Timber Pharmaceuticals, Inc.
Timber Pharmaceuticals, Inc. (TMBR) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
tmbr · stock forecast · 1 analysts (3M) · FMP · updated Nov 25, 2024
Analyst Rating & Consensus
Based on 1 Wall Street analysts in the past 3 months
Hold
1 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $0.01
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $0.01 | ↑ 0.00% |
1-day model range: $0.01–$0.01. Peak: $0.01 (+0.00%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · TMBR · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2023-08-28 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2023-08-27 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2023-04-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2022-10-26 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2022-08-29 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2022-05-02 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2022-03-31 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Timber Pharmaceuticals, Inc. (TMBR) stock. Of the recent 7 rating actions, 0 were upgrades and 2 were downgrades. 1 analysts currently cover TMBR.
Analyst Recommendation Trends
TMBR analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
—
Revenue Next Year
—
EPS This Year
—
EPS Next Year
—
EPS ForecastReported vs Estimated
Analysts forecast TMBR EPS of $— for the current fiscal year, based on estimates from 0 analysts. The TMBR revenue forecast is — for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The TMBR stock forecast is supported by two independent data sources: analyst consensus ratings from 1 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus TMBR price target is $0.00 (+0.0% upside), with an analyst consensus of Hold.
The TMBR short-term stock prediction for tomorrow is $0.01 (+0.00%).
Timber Pharmaceuticals, Inc. trades on AMEX under the ticker TMBR. The TMBR stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 0% of covering analysts.
Frequently asked questions
TMBR forecast · 8 questionsAccording to 1 Wall Street analysts, the average 12-month TMBR price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $0.01.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.